课题基金 / 基金详情

Evaluation of COVID-19 antibody therapies

Evaluation of COVID-19 antibody therapies
COVID-19 抗体疗法的评估
批准号:
10285866
负责人:
Connie Schmaljohn
金额:
$5.41万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Connie Schmaljohn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The IRF has engaged in development of assays for detection and semi-quantification of neutralizing antibodies to SARS-CoV-2 as possible therapeutics. Advances in identification of pathogen specific antibodies and techniques for propagating and purifying them has allowed development of antibodies as potential therapeutics with reduced possibility of complications. The IRF has been working with multiple collaborators to evaluate antibody candidates as well as convalescent plasma in in-vitro neutralizing and total antibody assays and the hamster model of COVID-19.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical Assessment of a Multi-Head Electroporation Device for Delivery of Bio
  • 批准号:
    8499148
  • 项目类别:
  • 资助金额:
    $71.88万
  • 财政年份:
    2013
  • 负责人:
    Connie Schmaljohn
  • 依托单位:
Preclinical Assessment of a Multi-Head Electroporation Device for Delivery of Bio
  • 批准号:
    8649026
  • 项目类别:
  • 资助金额:
    $78.59万
  • 财政年份:
    2013
  • 负责人:
    Connie Schmaljohn
  • 依托单位:
Assessment of the Immunogenicity and Protective Efficacy of a Multiagent DNA Vacc
  • 批准号:
    7644658
  • 项目类别:
  • 资助金额:
    $37.51万
  • 财政年份:
    2009
  • 负责人:
    Connie Schmaljohn
  • 依托单位:
Assessment of the Immunogenicity and Protective Efficacy of a Multiagent DNA Vacc
  • 批准号:
    7938762
  • 项目类别:
  • 资助金额:
    $103.13万
  • 财政年份:
    2009
  • 负责人:
    Connie Schmaljohn
  • 依托单位:
海外基金